Author： Johnson Rebecca Sabnis Nirupama McConathy Walter J. Lacko Andras G.
Publisher： MDPI
E-ISSN： 1999-4923|5|2|353-370
ISSN： 1999-4923
Source： Pharmaceutics, Vol.5, Iss.2, 2013-06, pp. : 353-370
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
By Chiang Kun-Chun Yeh Ta-Sen Chen Shin-Cheh Pang Jong-Hwei S. Yeh Chun-Nan Hsu Jun-Te Chen Li-Wei Kuo Sheng-Fong Takano Masashi Kittaka Atsushi Chen Tai C. Sun Chi-Chin Juang Horng-Heng
International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. :
Access to resources
Recommend
β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
By Yin Hsin-Ling Wu Chun-Chieh Lin Chih-Hung Chai Chee-Yin Hou Ming-Feng Chang Shu-Jyuan Tsai Hung-Pei Hung Wen-Chun Pan Mei-Ren Luo Chi-Wen
International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. :
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
By Mercatali Laura Spadazzi Chiara Miserocchi Giacomo Liverani Chiara De Vita Alessandro Bongiovanni Alberto Recine Federica Amadori Dino Ibrahim Toni
International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-11 ,pp. :